So let me get this straight, you're suggesting that we should ignore the projected CAPEX estimate from Canaccord who just conducted a site visit, and also ignore the CAPEX spend of a peer in the same country, and just multiply a random figure by five and add inflation? That's ridiculous mate.
For a start, AGY haven't even finished spending on the 2 ktpa plant yet, with filtration equipment still being replaced as we speak. So you don't even know what the figure is to be multiplied, you're just picking $30m from the cap raise, but you're again conveniently forgetting about the options exercised in 2022 that contributed an additional ~$32m to the kitty. Where'd that cash go since you aren't accounting for it?
And $10m for the ponds? You've got to be joking. GLN just budgeted US$113.3m for 20 ktpa worth of ponds. Halve that to correspond with AGY's 10 ktpa operation, and you've got US$56.65m for 10 ktpa worth of ponds. Don't like peer comparisons? Take a look at AGY's own PEA from 2018, where they budgeted US$44.2m for the 10 ktpa ponds. If we adjust using your 30% inflation figure, that equates to a cost of US$57.46m, which is (give or take) equivalent to the cost of GLN's ponds. All good though, you were only off the mark by a factor of x 5.6!
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-18293
-
- There are more pages in this discussion • 5,193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.002(4.88%) |
Mkt cap ! $56.78M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $24.58K | 631.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 478587 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 256850 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 480732 | 0.039 |
7 | 364121 | 0.038 |
7 | 834127 | 0.037 |
11 | 1424852 | 0.036 |
28 | 3549934 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 253253 | 25 |
0.041 | 678232 | 5 |
0.042 | 242305 | 5 |
0.043 | 335646 | 5 |
0.044 | 1686077 | 7 |
Last trade - 12.00pm 13/08/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online